Mark R. Ziebell
2023
Compensation breakdown
| Non-Equity Incentive Plan | $172,200 |
|---|---|
| Salary | $423,308 |
| Stock Awards | $730,298 |
| Other | $51,593 |
| Total | $1,377,399 |
Ziebell received $730.3K in stock awards, accounting for 53% of the total pay in 2023.
Ziebell also received $172.2K in non-equity incentive plan, $423.3K in salary and $51.6K in other compensation.
Rankings
In 2023, Mark R. Ziebell's compensation ranked 867th out of 3,006 executives tracked by ExecPay. In other words, Ziebell earned more than 71.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 867 out of 3,006 | 71st |
Division Manufacturing | 509 out of 1,650 | 69th |
Major group Chemicals And Allied Products | 347 out of 918 | 62nd |
Industry group Drugs | 338 out of 881 | 62nd |
Industry Pharmaceutical Preparations | 228 out of 637 | 64th |
Pay ratio
| Mark R. Ziebell's Pay | $1,377,399 |
|---|---|
| Median Employee's Pay | $104,595 |
| Pay Ratio | 13to 1 |
In 2023, the annual total compensation of Mark R. Ziebell was $1,377,399.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,595.
The ratio of Mark R. Ziebell's pay to the pay of median employee was therefore 13 to one.
Ziebell's colleagues
We found four more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2023.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019
August 17, 2018